---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-004228"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:47:55.128162+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# VolitionRx prices $16.5M public offering of 13M shares at $1.27 per share

## Summary
- Gross proceeds of $16.5M from 13M shares at $1.27/share; net proceeds ~$15.4M.
- Underwriters granted 30-day option to buy up to 1.95M additional shares at same price.
- Net proceeds for R&D, clinical studies, commercialization, working capital, and possible M&A.
- Underwriter warrants issued to buy up to 448,500 shares at $2.00/share, exercisable after 6 months.
- Offering expected to close on June 5, 2023, subject to customary conditions.

## SEC filing metadata
- accession: 0001477932-23-004228
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793223004228/0001477932-23-004228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793223004228/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-004228
- JSON: https://secwatch.observer/filing/0001477932-23-004228.json
- Plain text: https://secwatch.observer/filing/0001477932-23-004228.txt

## Key facts
- Material Agreements
  VOLITIONRX LTD entered into Underwriting Agreement with Prime Executions, Inc., doing business as Freedom Capital Markets valued at approximately $15.4 million (effective 2023-06-01).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Prime Executions, Inc., doing business as Freedom Capital Markets
  - Value: approximately $15.4 million
  - Effective: 2023-06-01
  source text: On June 1, 2023, VolitionRx Limited (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Prime Executions, Inc., doing business as Freedom Capital Markets (“Freedom”), as representative of the underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of 13,000,000 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), to the Underwriters.
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793223004228/0001477932-23-004228-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.